Prabha Hullatti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Prabha Hullatti has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
A. P. Basavarajappa
Department of Pharmacology, Bapuji Pharmacy College, Davangere, India
1 shared publication- A. P. Basavarajappa1 shared publication
Nabarun Mukhopadhyay
Department of Chemical Sciences (Natural Products), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India
1 shared publication- Nabarun Mukhopadhyay
Department of Chemical Sciences (Natural Products), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India
1 shared publication Prabha Hullatti
1 shared publicationSamriti Faujdar
Department of Pharmacy, Banasthali Vidyapith, Rajasthan, India
1 shared publication
Latest Publications
- 1 July 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (5) , 243
Hydroalcoholic Leaf Extract of Cassia auriculata Modulates Inflammation, Oxidative Stress and Tissue Injury in Acetic Acid-Induced Ulcerative Colitis
- 1 July 2026
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (5) , 243
Hydroalcoholic Leaf Extract of Cassia auriculata Modulates Inflammation, Oxidative Stress and Tissue Injury in Acetic Acid-Induced Ulcerative Colitis
- Open Access
- 1 June 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 1-6
ROLE OF PLANT-BASED FLAVONOIDS AS DRUG CANDIDATES FOR INFLAMMATORY BOWEL DISEASE-A SHORT REVIEW
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.
- 1 June 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 1-6
Open AccessROLE OF PLANT-BASED FLAVONOIDS AS DRUG CANDIDATES FOR INFLAMMATORY BOWEL DISEASE-A SHORT REVIEW
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.